11 September 2018 - The Biosafety Advisory Council issues a positive advice (with conditions) for this trial
File:
Trial reference:
A phase 2 study to assess the safety and efficacy of GM Lactococcus lactis for the attenuation of oral mucositis in subjects with cancers of the head and neck